Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam Oral Solution Pediatric Sedation Study
CTR20231545Phase 4Completed
- Sponsor
- Yichang Humanwell Pharmaceutical Co., Ltd.
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of midazolam in Procedural anxiety, procedural sedation and analgesia (PSA), preoperative anxiety, sponsored by Yichang Humanwell Pharmaceutical Co., Ltd.. Started May 2023; status: completed.
02
Drugs
midazolam
03
Conditions
Procedural anxietyprocedural sedation and analgesia (PSA)preoperative anxiety
Beyond the preview
Go deeper on CTR20231545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231545.